期刊文献+

非洛地平缓释片治疗原发性高血压的谷峰比值与平滑指数研究 被引量:2

Study of the T/P ratio and smoothness index of Felodipine sustained-release tablet in the treatment of essential hypertension
下载PDF
导出
摘要 目的探讨非洛地平缓释片治疗轻中度原发性高血压患者的谷峰比值和平滑指数。方法对28例轻中度高血压患者,口服非洛地平缓释片5mg,1次/d,疗程8周,于治疗前后进行24h动态血压监测并计算谷峰比值和平滑指数。结果治疗8周后,24h收缩压和舒张压,白昼收缩压和舒张压,夜间收缩压和舒张压与治疗前比较均有显著性差异(P<0.01),T/P为收缩压69%,舒张压70%。平滑指数为收缩压(1.09±0.57),舒张压(0.94±0.51)。结论非洛地平缓释片有较高的T/P比值及良好的平滑指数。 Objective To observe the T/P ratio and smoothness index of Felodipine sustained-release tablet in the treatment of patients with light or moderate essential hypertension. Methods Twenty-eight patients with light or moderate hypertension were taken orally Felodipine sustained-release tablet 5mg, once a day, treatment period was 8 weeks, 24 hours ambulatory blood pressure monitoring after/before treatment were taken and the T/P radio and smoothness index were counted . Results Eight weeks after treatment, compared with before treatment, 24 hours systolic blood pressure and 24 hours diastolic blood pressure, night systolic blood pressure and diastolic blood pressure had very significantly differences (P〈0. 01) ,T/P was systolic blood pressure 69%, diastolic 70%, smoothness index was systolic blood pressure (1.09 ± 0.57), diastolic blood pressure was (0. 94± 0. 51). Conclusion Felodipine sustained-release tablet has higher T/P ratio and good smoothness index.
作者 门超
出处 《中国实用神经疾病杂志》 2008年第9期42-43,共2页 Chinese Journal of Practical Nervous Diseases
关键词 高血压 非洛地平缓释片 动态血压 谷峰比值 平滑指数 Hypertension Felodipine sustained-release tablet Ambulatory blood pressure R/P ratio Smoothness index
  • 相关文献

参考文献3

二级参考文献11

  • 1叶任高.内科学[M].北京:人民卫生出版社,1999.812.
  • 2MEREDITH PA, ELLIOTT HL. FDA guidelines on trough:peak ratios in the evalu ation ofantihypertensive agents [J]. J Cardiovasc Pharmacol,1994,23 Suppl 5 : S26-S30.
  • 3PARATI G, OMBONI S, RIZZONI D. The smoothness index: a new, reproducible andclinically relevant measure of the homogeneity of the blood pressure reducti on withtreatment for hypertension[J]. J Hypertens,1998, 16(11): 1685-1691.
  • 4GROPPELLI A, OMBONI S, PARATI G. Evaluation of noninvasive blood pressuremonitoring devices spacelabs 90202 and 90207 versus resting and ambulatory 24-h ourintra-arterial blood pressure[J]. Hypertension,1992,20(2):227-232.
  • 5OMBONI S, PARATI G, ZANCHETTI A. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects[J ]. JHypertens,1995,13(10):1105-1112.
  • 6BLAND JM, ALTMAN DG. Statistical methods for assessing agreement between t womethods of clinical measurement[J]. Lancet, 1986,1(8476):307-310.
  • 7MACCHIARULO C, PIERI R, MITOLO DC. Antihypertensive effects of six calciumantagonists: evidence from fourier analysis of 24-hour ambulatory blood pressu rerecordings. Curr Ther Res Clin Exp, 2001,62(4):236-253.
  • 8STAESSEN JA, THIJS L, MANCIA G. Clinical trials with ambulatory blood pres su remonitoring : fewer patients needed? Syst-Eur Investigators [J]. Lancet ,1994,344(8936):1552-1556.
  • 9ZANNAD F, BERNAUD CM, FAY R. Double-blind, randomized, multicentre compar iso n ofthe effects of amlodipine and perindopril on 24h therapeutic coverage and b eyond inpatients with mild to moderate hypertension [J]. J Hypertens,1999,17( 1):137-146.
  • 10WHO-Intemation Society of Hypertension Guideline Committee.1999,WHO -ISH guidelines for the management of hypersion J Hypertens,1999,17 (2):151-183

共引文献43

同被引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部